COVID-19与阿尔茨海默病的最新研究进展

doi:10.3969/j.issn.1003-9198.2023.05.021

摘要/Abstract

中图分类号:

R 749.16

张绍敏, 吴锦晖. COVID-19与阿尔茨海默病的最新研究进展[J]. 实用老年医学, 2023, 37(5): 521-523.

[1] BLAGOSKLONNY M V. From causes of aging to death from COVID-19[J]. Aging: Albany NY, 2020, 12(11):10004-10021.
[2] BEACH S, PRASCHAN N, HOGAN C, et al. Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement[J]. Gen Hosp Psychiatry, 2020, 65:47-53.
[3] WANG F Z, KREAM R M, STEFANO G B. Long-term respiratory and neurological sequelae of COVID-19[J]. Med Sci Monit, 2020, 26: e928996.
[4] DE ERAUSQUIN G A, SNYDER H, CARRILLO M, et al. The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning[J]. Alzheimers Dement, 2021, 17(6):1056-1065.
[5] BROWN E E, KUMAR S, RAJJI T K, et al. Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer's disease and related dementias[J]. Am J Geriatr Psychiatry, 2020, 28(7):712-721.
[6] ALONSO-LANA S, MARQUIÉ M, RUIZ A, et al. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia[J]. Front Aging Neurosci, 2020, 12:588872.
[7] HELMS J, KREMER S, MERDJI H, et al. Neurologic features in severe SARS-CoV-2 infection[J]. N Engl J Med,2020, 382(23):2268-2270.
[8] ATKINS J L, MASOLI J A H, DELGADO J, et al. Preexisting comorbidities predicting severe COVID-19 in older adults in the UK biobank community cohort[J]. J Gerontol A Biol Sci Med Sci, 2020, 75(11):2224-2230.
[9] AGNELLO L, PICCOLI T, VIDALI M, et al. Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis[J]. Scand J Clin Lab Invest, 2020, 80(4):313-317.
[10] MORADI MAJD R, MAYELI M, RAHMANI F. Pathogenesis and promising therapeutics of Alzheimer disease through eIF2alpha pathway and correspondent kinases[J]. Metab Brain, 2020, 35(8):1241-1250.
[11] SHAMIM D, LASKOWSKI M. Inhibition of inflammation mediated through the tumor necrosis factor α biochemical pathway can lead to favorable outcomes in Alzheimer disease[J]. J Cent Nerv Syst Dis, 2017, 9:117957351772251.
[12] MCKEE C M, COLL R C. NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma[J]. J Leukoc Biol, 2020, 108(3): 937-952.
[13] POLIDORO R B, HAGAN R S, D E SANTIS S R, et al. Overview: systemic inflammatory response derived from lung injury caused by SARS-CoV-2 infection explains severe outcomes in COVID-19[J]. Front Immunol, 2020, 11:1626.
[14] KALOVYRNA N, APOKOTOU O, BOULEKOU S, et al. A 3'UTR modification of the TNF-α mouse gene increases peripheral TNF-α and modulates the Alzheimer-like phenotype in 5XFAD mice[J]. Sci Rep, 2020, 10(1):8670.
[15] FREEMAN T L, SWARTZ T H. Targeting the NLRP3 inflammasome in severe COVID-19[J]. Front Immunol, 2020, 11:1518.
[16] DING H G, DENG Y Y, YANG R Q, et al. Hypercapnia induces IL-1beta overproduction viaactivation of NLRP3 inflammasome: implication in cognitive impairment in hypoxemic adult rats[J]. J Neuroinflammation, 2018, 15(1):4.
[17] MILOVANOVIC J, ARSENIJEVIC A, STOJANOVIC B, et al. Interleukin-17 in chronic inflammatory neurological diseases[J]. Front Immunol, 2020, 11:947.
[18] MUNOZ P, ARDILES A O, PEREZ-ESPINOSA B, et al. Redox modifications in synaptic components as biomarkers of cognitive status, in brain aging and disease[J]. Mech Ageing Dev, 2020, 189:111250.
[19] LABANDEIRA-GARCIA J L, GARRIDO-GIL P, RODRIGUEZ-PALLARES J, et al. Brain renin-angiotensin system and dopaminergic cell vulnerability[J]. Front Neuroanat, 2014, 8:67.
[20] LIM K H, YANG S, KIM S H, et al. Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease[J]. J Infect, 2020, 81(3): e33-e34.
[21] POLITI L S, SALSANO E, GRIMALDI M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019(COVID-19) and anosmia[J]. JAMA Neurol, 2020, 77(8):1028-1029.
[22] LIMA M, SIOKAS V, ALOIZOU A M, et al. Unraveling the possible routes of SARS-COV-2 invasion into the central nervous system[J]. Curr Treat Options Neurol, 2020, 22(11):37.
[23] WANG H L, TANG X J, FAN H, et al. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients[J]. Aging:Albany NY, 2020, 12(11):10022-10034.
[24] DELGADO-ROCHE L, MESTA F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus(SARS-CoV)infection[J]. Arch Med Res, 2020, 51(5):384-387.
[25] PANFOLI I. Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis[J]. Clin Med:Lond, 2020, 20(5):e146-e147.
[26] NASI A, MCARDLE S, GAUDERNACK G, et al. Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention[J]. Toxicol Rep, 2020, 7:768-771.
[27] HARDAS S S, SULTANA R, CLARK A M, et al. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain[J]. Redox Biol, 2013, 1(1):80-85.
[28] BOSTANCIKLIOGLU M. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research[J]. Curr Neurovasc Res, 2020, 17(4):342-343.
[29] ENNERFELT H E, LUKENS J R. The role of innate immunity in Alzheimer's disease[J]. Immunol Rev, 2020, 297(1):225-246.

COVID-19与阿尔茨海默病的最新研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 12

Metrics

推荐阅读 10

[1]	孙丽, 尹卫红, 经俊, 钱夏丽. 亚麻醉剂量艾司氯胺酮对老年脊柱手术病人术后早期认知功能障碍的影响[J]. 实用老年医学, 2024, 38(10): 1039-1043.
[2]	董丽华, 李加梅, 郑加平, 雷小晶. 血液生物标志物在阿尔茨海默病早期诊断中的研究进展[J]. 实用老年医学, 2023, 37(12): 1249-1254.
[3]	张伟, 王蓉. 衰老作为神经退行性疾病危险因素的科学现状分析[J]. 实用老年医学, 2023, 37(10): 984-988.
[4]	时建铨, 郑慧芬, 徐畅, 王变荣. 认知障碍简明评价量表与Addenbrooke认知评估量表Ⅲ诊断阿尔茨海默病的准确性比较[J]. 实用老年医学, 2023, 37(10): 1041-1043.
[5]	阎子花, 杜静, 宋竹梅, 张兴梅, 张楠. 痴呆病人病感失认测评工具的研究进展[J]. 实用老年医学, 2023, 37(10): 1059-1063.
[6]	王琳琳, 杨诗怡, 徐俊. 人工智能在阿尔茨海默病中的研究进展[J]. 实用老年医学, 2023, 37(9): 869-872.
[7]	王敏, 郭文军, 汤忠泉, 赵晓敏, 欧婷, 李云涛. 听力障碍与阿尔茨海默病相关性的Meta分析[J]. 实用老年医学, 2023, 37(9): 915-919.
[8]	段景宜, 刘静, 查玉航, 杨巧露, 何海洋, 马亚男, 高海英. 阿尔茨海默病医防融合模式的探索[J]. 实用老年医学, 2023, 37(8): 757-760.
[9]	赵璨, 冯美江. 外泌体与阿尔茨海默病的研究进展[J]. 实用老年医学, 2023, 37(4): 335-338.
[10]	朱贺, 殷实. 认知障碍与抑郁症关系的研究进展[J]. 实用老年医学, 2023, 37(3): 234-237.
[11]	郭晓娟, 刘洁, 王瑾, 陆文惠, 高玲, 屈秋民. 西安地区阿尔茨海默病病人药物依从性调查及影响因素分析[J]. 实用老年医学, 2023, 37(1): 47-50.
[12]	叶念思, 胡慧, 邓蓓, 刘雪婷, 周诗, 李雨灿, 王晓梦. 轻度认知障碍老年人口腔健康相关生活质量现状及影响因素分析[J]. 实用老年医学, 2024, 38(7): 674-678.